2023 RNDS | AQP4/MOG tolerization research @wearesrna
2023 RNDS | AQP4/MOG tolerization research @wearesrna
Uploaded November 2023 | Updated September 2026, 1 week ago
At the 2023 Regional RNDS, Dr. Peter Sguigna of the University of Texas Southwestern Medical Center discussed tolerization and current research in AQP4-positive NMOSD and MOGAD.
2023 RNDS | AQP4/MOG tolerization research2025 RNDS | Whats new at SRNA: Programs and events2025 RNDS | Symptom management panel601. Body Dysmorphia2024 RNDS | Synaptic Dysfunction in Rare Neuroimmune Disorders602. NMOSD and Romantic Relationships2025 RNDS en Español | Aliados de la comunidad2023 RNDS | Transplantation of human glial restricted progenitor cells into patients with TM205. Dr. Alexandra Kornbluh2023 RNDS en Español | Entendiendo los trastornos neuroinmunológicos poco frecuentes en niños403. I-CAN, A Study of Inebilizumab in Children with AQP4+ NMOSD2023 RNDS | Care for the caregivers
SRNA |

2023 RNDS | AQP4/MOG tolerization research

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER